Jefferson University Hospitals

Provider Profile

Marinos C. Dalakas, MD

Marinos C. Dalakas, MD

Jefferson University Physician

Academic Title: Professor

Specialties
Neurology - Neuromuscular

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
909 Walnut Street
2nd Floor, COB Bldg.
Philadelphia PA 19107
Phone: (215) 955-7952
Fax: (215) 955-9976

Board Certifications

  • Neurology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Notes

Director, Neuromuscular Division

Education

  • University of Athens, Greece, Medical School

Internship

  • Ellis Hospital, New York

Residency

  • University of Medicine & Dentistry of New Jersey

Fellowship

  • National Institute of Health

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • AmeriHealth
  • AmeriHealth Comprehensive
  • AmeriHealth HMO
  • AmeriHealth Personal Choice
  • Blue Cross/Blue Shield
  • Cigna Healthspring
  • Cigna PPO, POS
  • Consumer Health Network PPO
  • CorVel
  • Devon
  • Employers Health Network PPO
  • Evolutions (Guardian Resources)
  • Federal BCBS
  • Geisinger Health Plan
  • Health America PPO
  • Health Management Network PPO
  • Horizon Blue Cross/Blue Shield
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone First VIP Choice
  • Keystone Health Plan East
  • Medicare
  • Mercy LIFE
  • MultiPlan Inc.
  • NJ Plus
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • Preferred Care PPO
  • Premier Blue
  • Prime Health Services, Inc.
  • Qualcare
  • Tricare
  • United Healthcare
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan

Recent Publications

Myositis: Are autoantibodies pathogenic in necrotizing myopathy?

Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy

Advances in the diagnosis, immunopathogenesis and therapies of igm-anti-mag antibody-mediated neuropathies

Gene therapy for Duchenne muscular dystrophy: Balancing good science, marginal efficacy, high emotions and excessive cost

A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome

Rituximab in anti-MAG neuropathy: More evidence for efficacy and more predictive factors

International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis

Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations

Treating myasthenia on consensus guide: Helpful and challenging but still unfinished business

Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM

Close to the node but far enough

Viruses in IBM: Hit-and-run, hide and persist, or irrelevant?

The spectrum of inflammatory myopathies: Dermatomyositis, polymyositis, necrotizing myositis, and inclusion-body myositis

Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future

Necrotising autoimmune myopathy (NAM): Antibodies seem to be specific markers in aiding diagnosis

Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity

Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials

Efficacy of Intravenous Immunoglobulin in Neurological Diseases